A combination therapy of low-dose chemotherapy with paclitaxel and the targeted drug trastuzumab (Herceptin) showed promising results in women with early stage HER2-positive breast cancer, according to researchers at Dana-Farber Cancer Institute in Massachusetts. Women who received the treatment were highly unlikely to see their cancer return.
406 women whose tumors were smaller than three centimeters and had not spread to their lymph nodes were part of the phase II clinical trial. These women were treated with the combination therapy for 12 weeks, followed by 9 months of Herceptin alone.
Breast Cancer during Pregnancy
Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.
Advertisement
Senior author of the study, Eric Winer, said, "Women with small, HER-2 positive, node-negative breast tumors have a low, but still significant, risk of recurrence of their disease. This study demonstrates that a combination of lower-intensity chemotherapy and trastuzumab, which is associated with fewer side effects than traditional chemotherapy regimens, is an appealing standard of care for this group of patients."
The researchers said, "Three years after completing the combination therapy, 98.7 percent of the participants were alive and free of invasive breast cancer."
![Male Breast Cancer]( "Male Breast Cancer")
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.
However, Charles Shapiro, co-director of Dubin Breast Center, The Mount Sinai Hospital in New York, said, "Three years of follow-up is short, and time will tell if there are late recurrences."
The study appears in the New England Journal of Medicine.
Source: Medindia
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.
Advertisement
However, Charles Shapiro, co-director of Dubin Breast Center, The Mount Sinai Hospital in New York, said, "Three years of follow-up is short, and time will tell if there are late recurrences."
The study appears in the New England Journal of Medicine.
Source: Medindia
Screening for Breast Cancer with Clinical Breast Examination
Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.
Advertisement
 Breast Cancer - Prevention and Management with Lifestyle ChangesLifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
The mechanism by which the kinases cause inflammation has been discovered by scientists.